Gaviscon Liquid
NDC Package 0135-0095-41
Package Information
Gaviscon (aluminum hydroxide and magnesium carbonate) liquids is a medication used to treat the symptoms of too much stomach acid such as stomach upset, heartburn, and acid indigestion. This formulation utilizes a liquid delivery system. Marketed by Haleon Us Holdings Llc, this product is identified by NDC 0135-0095 and is authorized under FDA application M001.
Identification & Billing
- RxCUI: 1251365 - Gaviscon Regular Strength 95 MG / 358 MG in 15 mL Oral Suspension
- RxCUI: 1251365 - aluminum hydroxide 6.33 MG/ML / magnesium carbonate 23.9 MG/ML Oral Suspension [Gaviscon]
- RxCUI: 1251365 - Gaviscon (aluminum hydroxide 31.7 MG / magnesium carbonate 119.3 MG) per 5 ML Oral Suspension
- RxCUI: 1251365 - Gaviscon (aluminum hydroxide 95 MG / magnesium carbonate 358 MG) per 15 ML Oral Suspension
- RxCUI: 245001 - aluminum hydroxide 254 MG / magnesium carbonate 237.5 MG in 5 mL Oral Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0135 - Haleon Us Holdings Llc
- 0135-0095 - Gaviscon
- 0135-0095-41 - 355 mL in 1 BOTTLE
- 0135-0095 - Gaviscon
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0135-0095-41 identifies a specific commercial package of 355 ml in 1 bottle of Gaviscon, a human over the counter drug labeled by Haleon Us Holdings Llc. This liquid is formulated for oral use and contains aluminum hydroxide; magnesium carbonate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Haleon Us Holdings Llc on January 14, 2011. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used to treat the symptoms of too much stomach acid such as stomach upset, heartburn, and acid indigestion. Aluminum and magnesium antacids work quickly to lower the acid in the stomach. Liquid antacids usually work faster/better than tablets or capsules. This medication works only on existing acid in the stomach. It does not prevent acid production. It may be used alone or with other medications that lower acid production (including H2 blockers such as cimetidine/ranitidine and proton pump inhibitors such as omeprazole).
How is this Haleon Us Holdings Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00135009541. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 355 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.